EIRL’s product lineup
Brain aneurysm detection support technology advanced from MRA
Diagnostic support for detecting brain aneurysms from brain MRA
Automatic extraction of intracranial high attenuation areas from head CT images
Tokyo, Japan – May 31, 2018 –LPixel Inc., a leader in AI-powered medical diagnostic support technologies, is pleased to announce a partnership with EnvoyAI, the leading artificial intelligence distribution platform provider based in Cambridge, Massachusetts. This partnership is anticipated to accelerate LPixel’s global expansion and enable a seamless integration of LPixel’s algorithms into the clinical workflow. Each algorithm will be available via the EnvoyAI platform, initially for research use, after completing the EnvoyAI machine qualification process. EnvoyAI will be demoing LPixel’s AI technology, EIRL, at the Society for Imaging Informatics in Medicine 2018 Annual Meeting in National Harbor, Maryland from May 31 through June 2. Demonstrations will be available at the EnvoyAI booth #103 – Start Up Street.
EIRL is the collective name given to LPixel’s AI-based medical image diagnostic support technology. LPixel has implemented EIRL in the ongoing research and development of various areas of medical image diagnostics, such as MRI scans of the brain and breasts, chest X-rays, large intestine endoscopy and pathology. LPixel will perform the necessary procedures in accordance with the applicable laws and regulations to allow the use of EIRL in medical applications.
EnvoyAI provides a developer platform, integrations, and an API interface for algorithm developers, technology partners, and end users. EnvoyAI facilitates the streamlined distribution and hospital implementation of trained machine learning algorithms via a vendor neutral distribution platform. The platform allows users anywhere to access cloud-based algorithms without requiring access to the algorithm code or training data to protect PHI and developer intellectual property. EnvoyAI assists research institutions and emerging AI companies in the translation and commercialization processes, starting with rapid deployment via a scalable, secure, cloud-based infrastructure with the ability to add local components to facilitate on-site deployments as well. EnvoyAI also works with distribution partners to make algorithms on the platform available to a very wide footprint of hospitals and, ultimately, to physicians.
LPixel is a leader in advanced image analysis and processing technology encompassing the life science field. Founded in March 2014, LPixel is dedicated to offering research facilities top-tier image analysis and medical diagnosis technologies, both of which are powered by AI. The company is currently working with the University of Tokyo, the National Cancer Center Japan and other research institutions to further the development of its AI-based medical diagnosis technology. For more information, please visit https://lpixel.net/en/